Why Tide Labs keeps compounds separate Every compound remains in its own vial so researchers can track lot numbers, storage behaviour, reconstitution choices, and concentration independently
Tim Lobstein et al., World Obesity Atlas 2023, World Obesity Federation (March 2023), accessed February 28, 2025, [7]
Due to the evidence from these trials, in May 2022, tirzepatide received FDA approval to improve glycemic control in patients with T2D as an adjunct to diet and exercise [37]
Banjac A, Perisic T, Sato H, Seiler A, Bannai S, Weiss N et al
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding predispositions in peptide signaling pathways relevant to mood regulation and GLP-1 responsiveness